| College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer ME Hammond, DF Hayes, M Dowsett, DC Allred, KL Hagerty, S Badve, ... J Clin Oncol 28 (16), 2784-2795, 2010 | 6183* | 2010 |
| The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ... Annals of oncology 26 (2), 259-271, 2015 | 2985 | 2015 |
| Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ... New England Journal of Medicine 379 (2), 111-121, 2018 | 2268 | 2018 |
| Prospective validation of a 21-gene expression assay in breast cancer JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ... New England Journal of Medicine 373 (21), 2005-2014, 2015 | 1573 | 2015 |
| Derivation of hepatocytes from bone marrow cells in mice after radiation‐induced myeloablation ND Theise, S Badve, R Saxena, O Henegariu, S Sell, JM Crawford, ... Hepatology 31 (1), 235-240, 2000 | 1511 | 2000 |
| Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199 S Adams, RJ Gray, S Demaria, L Goldstein, EA Perez, LN Shulman, ... Journal of clinical oncology 32 (27), 2959-2966, 2014 | 1430 | 2014 |
| Breast cancer prognostic classification in the molecular era: the role of histological grade EA Rakha, JS Reis-Filho, F Baehner, DJ Dabbs, T Decker, V Eusebi, ... Breast cancer research 12, 1-12, 2010 | 1335 | 2010 |
| CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis C Sheridan, H Kishimoto, RK Fuchs, S Mehrotra, P Bhat-Nakshatri, ... Breast Cancer Research 8, 1-13, 2006 | 1310 | 2006 |
| Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists S Badve, DJ Dabbs, SJ Schnitt, FL Baehner, T Decker, V Eusebi, SB Fox, ... Modern pathology 24 (2), 157-167, 2011 | 968 | 2011 |
| Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (6), 311-335, 2017 | 794 | 2017 |
| Tumor-infiltrating lymphocytes and prognosis: a pooled individual patient analysis of early-stage triple-negative breast cancers S Loi, D Drubay, S Adams, G Pruneri, PA Francis, M Lacroix-Triki, ... Journal of clinical oncology 37 (7), 559-569, 2019 | 764 | 2019 |
| NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2 HL Chua, P Bhat-Nakshatri, SE Clare, A Morimiya, S Badve, H Nakshatri Oncogene 26 (5), 711-724, 2007 | 760 | 2007 |
| Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with … BP Schneider, M Wang, M Radovich, GW Sledge, S Badve, A Thor, ... Journal of Clinical Oncology 26 (28), 4672-4678, 2008 | 734 | 2008 |
| A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors MR Choi, KJ Stanton-Maxey, JK Stanley, CS Levin, R Bardhan, D Akin, ... Nano letters 7 (12), 3759-3765, 2007 | 697 | 2007 |
| Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (5), 235-251, 2017 | 696 | 2017 |
| Assessment of Ki67 in breast cancer: updated recommendations from the international Ki67 in breast cancer working group TO Nielsen, SCY Leung, DL Rimm, A Dodson, B Acs, S Badve, C Denkert, ... JNCI: Journal of the National Cancer Institute 113 (7), 808-819, 2021 | 600 | 2021 |
| A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast LJ Solin, R Gray, FL Baehner, SM Butler, LL Hughes, C Yoshizawa, ... Journal of the National Cancer Institute 105 (10), 701-710, 2013 | 597 | 2013 |
| Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer JA Sparano, RJ Gray, PM Ravdin, DF Makower, KI Pritchard, KS Albain, ... New England journal of medicine 380 (25), 2395-2405, 2019 | 499 | 2019 |
| Phyllodes tumours of the breast: a consensus review BY Tan, G Acs, SK Apple, S Badve, IJ Bleiweiss, E Brogi, JP Calvo, ... Histopathology 68 (1), 5-21, 2016 | 476 | 2016 |
| Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia International Consensus Group for Hepatocellular Neoplasia Hepatology 49 (2), 658-664, 2009 | 471 | 2009 |
nakshatri*Professor, Indiana University School of MedicineVerified email at iupui.edu
